Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03472274 |
| Title | Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) (DUTRENEO) |
| Acronym | DUTRENEO |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fundacion CRIS de Investigacion para Vencer el Cancer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| ICO Badalona | Badalona | Spain | Details | |||
| Hospital Clinic | Barcelona | Spain | Details | |||
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | Details | |||
| ICO L'Hospitalet | L'Hospitalet De Llobregat | Spain | Details | |||
| Hospital 12 de Octubre | Madrid | Spain | Details | |||
| Hospital Clinico San Carlos | Madrid | Spain | Details | |||
| Hospital Ramon y Cajal | Madrid | Spain | Details | |||
| Hospital Universitario La Paz | Madrid | Spain | Details | |||
| MD Anderson Cancer Center | Madrid | Spain | Details | |||
| Hospital Marqués de Valdecilla | Santander | Spain | Details | |||
| Instituto Valenciano de Oncología | Valencia | Spain | Details |